A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

Source: RI-MUHC

Classified as: breast cancer, Research Institute of the McGill University Health Centre (RI-MUHC)
Published on: 3 Jun 2021

Using a new technique, a team of McGill University researchers has found tiny and previously undetectable ‘hot spots’ of extremely high stiffness inside aggressive and invasive breast cancer tumours. Their findings suggest, for the first time, that only very tiny regions of a tumor need to stiffen for metastasis to take place. Though still in its infancy, the researchers believe that their technique may prove useful in detecting and mapping the progression of aggressive cancers.

Classified as: Faculty of Engineering, breast cancer, Research, Rosalind and Morris Goodman Cancer Research Centre, faculty of medicine
Published on: 27 Oct 2020

Marc Miller, Member of Parliament (Ville-Marie–Le Sud-Ouest–Île-des-Sœurs, Quebec) and Parliamentary Secretary to the Minister of Crown-Indigenous Relations, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, announced today at McGill an investment of up to $6 million for a scientific task force of top researchers to develop new and improved approaches to cancer treatment and care. The funding will be distributed over four years to the new pan-Canadian program, the Stand Up to Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team.

Classified as: stand up to cancer, Nahum Sonenberg, Michael Pollak, faculty of medicine, Oncology, breast cancer
Published on: 12 Aug 2019

Source: Terry Fox Research Institute

What is the best way to starve cancer cells? What role does obesity play in metastatic breast cancer and how does it affect the tumour microenvironment? Might combining a chemotherapeutic agent with a drug now used to treat diabetes be part of an effective therapy for metastatic breast cancer?

Classified as: breast cancer, Goodman Cancer Research Centre
Published on: 4 Jul 2019

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival was prolonged in patients who expressed the prolactin receptor and that prolactin hormone was able to reduce the aggressive behavior of cancerous cells. It does so by decreasing their ability to divide and form new tumors.

Classified as: RI-MUHC, breast cancer, Women's Health, Cancer Research Program
Category:
Published on: 25 Oct 2016

A new study of over 3,400 Canadian women provides further evidence that exposure to air-pollution may increase the risk of developing breast cancer, especially among women who have not yet had their menopause.

Classified as: Research, Cancer, pollution, breast cancer, breast cancer causes, cancer causes, golberg
Published on: 5 Dec 2014
Back to top